PRFX is trading at $1.43 (5.3% down) as the stock continues to face downward pressure despite a lack of new company-specific catalysts identified for June 29.
- The decline appears to be stock-specific rather than market-driven, as broader indices are firmer today while the micro-cap suffers from fading momentum and thin liquidity.
- Recent news regarding DeepSolar Predict progress and PRF-110 preclinical data has failed to provide a sustained lift, with the stock currently extending a recent trend of high volatility and weak follow-through.